← 產業報告目錄
Digital Therapeutics & Medical Devices for Migraine Market Size, Share & Trends Analysis Report By Type (Arm Device, Neck Device, Head/Forehead Device, and Others), By Age Group (Above 18 Years and Above 12 Years), By Mode of Action (Electrical Pulse, Mild Electrical Stimulation, and Deep Muscle Treatment), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-23頁數 180報告編號 INSIGHTACE-e80c64fefa
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Digital Therapeutics & Medical Devices for Migraine Market is positioned for steady expansion, with a projected CAGR of 8.6% from 2024 to 2031.
The Digital Therapeutics & Medical Devices for Migraine sector involves dynamics.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and rising investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Therapeutics & Medical Devices for Migraine Market Snapshot
Chapter 4. Global Digital Therapeutics & Medical Devices for Migraine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type, Estimates & Trend Analysis
5.1. By Type, & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:
5.2.1. Arm Device
5.2.2. Neck Device
5.2.3. Head/Forehead Device
5.2.4. Others
Chapter 6. Market Segmentation 2: By Age Group Estimates & Trend Analysis
6.1. By Age Group & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Age Group:
6.2.1. Above 18 Years
6.2.2. Above 12 Years
Chapter 7. Market Segmentation 3: By Mode Of Action Estimates & Trend Analysis
7.1. By Mode Of Action & Market Share, 2019 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mode Of Action:
7.2.1. Electrical Pulse
7.2.2. Mild Electrical Stimulation
7.2.3. Deep Muscle Treatment
Chapter 8. Digital Therapeutics & Medical Devices for Migraine Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Type, 2019-2031
8.1.2. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031
8.1.3. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts By Mode Of Action, 2019-2031
8.1.4. North America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.2.2. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.2.3. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.2.4. Europe Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, 2019-2031
8.3.2. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, 2019-2031
8.3.3. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, 2019-2031
8.3.4. Asia Pacific Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.4.2. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.4.3. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.4.4. Latin America Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Type, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) By Mode Of Action, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Digital Therapeutics & Medical Devices for Migraine Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Relivion MG
9.2.2. gammaCore
9.2.3. WeatherX
9.2.4. Aculief
9.2.5. Theragun
9.2.6. Allay Lamp
9.2.7. Shakti Mat
9.2.8. Allodynic Therapeutics, LLC
9.2.9. Amgen Inc.
9.2.10. Bayer AG
9.2.11. Cefaly Technology
9.2.12. Cirrus Healthcare Products
9.2.13. electroCore, Inc
9.2.14. Eli Lilly and Company
9.2.15. eNeura Inc.
9.2.16. GlaxoSmithKline plc.
9.2.17. Neurolief Ltd.
9.2.18. Neuros Medical, Inc.
9.2.19. Novartis AG
9.2.20. Pfizer Inc.
9.2.21. Salvia BioElectronics B.V.
9.2.22. Theranica Bio-Electronics Ltd.
9.2.23. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們